Reavaliação favorável pela Scopus
Retos has been re-evaluated by Scopus favorably, maintaining its current position in the 78th percentile (Q1) of CiteScore
It is ranked in the 68th percentile (Q2) in Education; 64th percentile (Q2) in Physiotherapy, Sports Therapy and Rehabilitation; 59th percentile (Q2) in Orthopedics and Sports Medicine; 78th percentile (Q1) in Pharmacy. Likewise, in Scimago Journal Rank it is in Q2 in Education; in Physiotherapy, Sports Therapy and Rehabilitation; in Q3 in Orthopedics and Sports Medicine.
https://www.scopus.com/sourceid/21100468901#tabs=0
Outcome of the re-evaluation
Fecha: El miércoles, 18 dic 2024 a las 21:22
Asunto: The re-evaluation of "Retos (Spain)" for Scopus is complete
Title: Retos (Spain)
ISSN / E-ISSN: 1579-1726 / 1988-2041
Publisher: Federación Española de Docentes de Educación Física - JURUFRA
Dear Francisco Ruiz Juan,
The title mentioned above has been re-evaluated by the Scopus Content Selection & Advisory Board (CSAB) to determine whether the title meets the content selection standards of Scopus today. The re-evaluation of this title is now complete and it was decided to continue with the indexing of this title in Scopus and any content that was paused during the re-evaluation will be added to Scopus within 4 weeks.
For your information, the reason for making this decision is:
Sample papers are by a mix of international authors - though some have a relatively large number of authors per published paper. Paper quality and cited references are generally good. The journal's commissioned report has clearly outlined the problem of group submission and citation patterns by authors from Indonesia. The journal's website has now indicated a clear statement on how to reduce unwarranted oversubmission and self-citations in potential papers: https://recyt.fecyt.es/index.php/retos/Ajustes. We are am reasonably comfortable with this quick editorial action. The decision is to continue indexing for now and recheck this title in the near future.
…
Yours sincerely,
The Scopus Team
Ler mais sobre Reavaliação favorável pela Scopus